Business

Organigram announces resignation of Dr. Kenneth Mitton from Board of Directors

Organigram announces resignation of Dr. Kenneth Mitton from Board of Directors Can...

articleOrganigram Global Inc.April 3, 20194/company/organigram-holdings-inc/news/organigram-announces-resignation-of-dr-kenneth-mitton-from-board-of-directors
Organigram announces resignation of Dr. Kenneth Mitton from Board of Directors

About this update from Organigram Global Inc.

[{"type":"text","content":"\n\n\n\nOrganigram announces resignation of Dr. Kenneth Mitton from Board of Directors\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMONCTON, NB, April 3, 2019\n\n\n\nMONCTON, NB, April 3, 2019 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the \"Company\" or \"Organigram\"), a leading licensed producer of cannabis announces the resignation of Dr. Kenneth Mitton from the Company's Board of Directors.\n\n \n \n\n \nDr. Mitton is a highly respected physician with more than 30 years' experience as a family doctor who joined the Organigram Board of Directors in 2014. His medical expertise and clinical insights have been invaluable to the Company as it has evolved from a licensed producer of medical cannabis to a national player in Canada's legal adult use recreational cannabis marketplace.\n\"We would like to thank Dr. Mitton for his significant contributions to Organigram and wish him continued success,\" said Greg Engel, CEO, Organigram.\nThe recruitment of a new member of the Board of Directors is currently underway.\nAbout Organigram Holdings Inc. \nOrganigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.\nOrganigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram's primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).\nNeither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility...

More updates from Organigram Global Inc.